IP Library Assignment 046842/0175
Patent Assignment
Reel/Frame 046842/0175

Assignment of Assignor's Interest

Recorded: 2018-09-11 Pages: 6
Assignors
ZHANG, XIAOMING
Executed: 2013-06-21
SCHNIPPER, EDWARD F.
Executed: 2013-06-21
PERLMAN, ANDREW J.
Executed: 2013-06-24
LARRICK, JAMES W.
Executed: 2013-06-21
Assignee
TIGERCAT PHARMA, INC.
400 OYSTER POINT BLVD., SUITE 202, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (2)
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,974,769 →
Application: 15/626,001 →
Publication: US 2017/0348282
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Application: 15/956,102 →
Publication: US 2018/0325867
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Sep 11, 2018
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 047051/0187 →
Patent Security Agreement Mar 9, 2020
From: MENLO THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0980 →
Change of Name Dec 1, 2020
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 054558/0437 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →